دورية أكاديمية

Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia.

التفاصيل البيبلوغرافية
العنوان: Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia.
المؤلفون: Akbar, Sheikh Mohammad Fazle, Al Mahtab, Mamun, Begum, Ferdousi, Hossain, Shaikh A. Shahed, Sarker, Sukumar, Shrestha, Ananta, Khan, Md. Sakirul Islam, Yoshida, Osamu, Hiasa, Yoichi, Tan, Yee-Joo
المصدر: Vaccines; Apr2021, Vol. 9 Issue 4, p374, 1p
مصطلحات موضوعية: HEPATITIS B vaccines, HEPATITIS B virus, HEPATITIS associated antigen, HEPATITIS B
مصطلحات جغرافية: SOUTHEAST Asia
الشركة/الكيان: WORLD Health Organization
مستخلص: The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunization (EPI) and vaccinating all infants and children three times within 1 year of birth (HepB3). Recently, the WHO advocate birth-dose hepatitis B vaccination (HepB-BD) as soon as possible after birth, preferably within 24 hours. In 2016, the SEARO endorsed a regional hepatitis B control goal with a target of hepatitis B surface antigen (HBsAg) seroprevalence of ≤1% among children aged ≥5 years by 2020. Of the 11 SEARO countries, four achieved this target on schedule. Out of these four countries, two countries (Bangladesh and Nepal) have not adopted HepB-BD in EPI program. On the other hand, the coverage of HepB3 is not satisfactory in some SEARO countries, including India which adopted HepB-BD but could not achieve the overall target of SEARO. Thus, it is a point of debate whether emphasis should be placed on proper implementation of HepB3 or whether a new agenda of HepB-BD should be incorporated in developing countries of SEARO. The article discusses strengthening and expanding the Hepatitis B vaccination program in SEARO countries with an emphasis on HepB and HepB-BD programs. [ABSTRACT FROM AUTHOR]
Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:2076393X
DOI:10.3390/vaccines9040374